LexaGene Holdings
Cash Flow

Last updated:

Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of LexaGene Holdings generated cash of -$11,525,250, which is less than the previous year. Cash used in financing activities reached the amount of $19,710,795 last year. Net change in cash is therefore $7,973,305.

Cash Flow

LexaGene Holdings Inc. (LSE:0V43.L): Cash Flow
2016 -51.53K -74.47K 152.46K
2018 -4.70M -863.21K 7.70M
2020 -7.26M -85.78K 10.92M
2021 -11.52M -86.71K 19.71M

0V43.L Cash Flow Statement (2015 – 2020)

2020 2019 2017 2015
Cash at beginning of period
4.27M882.87K1.15M0
Operating activities
Net income
-13.03M-10.06M-5.13M-80.37K
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation and amortization
604.35K681.08K24.85K4.53K
Stock-based compensation expense
765.49K2.13M553.26K0
Deferred income tax benefit 765.49K2.13M553.26K0
Changes in operating assets and liabilities:
Accounts receivable, net
-52.09K-4.24K-1.61K-1.36K
Inventories
-1.35M000
Accounts payable
0000
Cash generated by operating activities
-11.52M-7.26M-4.70M-51.53K
Investing activities
Purchases Of Investments
0000
Investments In Property Plant And Equipment
-86.71K-85.78K-850.37K0
Acquisitions Net
0000
Cash generated by investing activities
-86.71K-85.78K-863.21K-74.47K
Financing activities
Common Stock Issued
0000
Payments for dividends
0000
Repurchases of common stock
0000
Repayments of term debt
-493.98K000
Cash used in financing activities
19.71M10.92M7.70M152.46K
Net Change In Cash
7.97M3.39M2.24M25.32K
Cash at end of period
12.24M4.27M3.39M25.32K
Data sourceData sourceData sourceData source